Atomized salbutamol solution for treating respiratory diseases and preparation method thereof

A technology for albuterol and respiratory diseases, applied in the field of atomized albuterol solution, can solve the problems of increasing the risk of clinical drug use, affecting product quality, and difficult to repair and protect the mucosa in the lungs, so as to reduce the risk of clinical drug use and improve drug use. The effect of safety and excellent stability

Inactive Publication Date: 2019-07-26
南京望知星医药科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In order to make the solution exhibit better long-term stability, auxiliary materials such as preservatives, stabilizers, antioxidants, osmotic pressure regulators, metal ion complexing agents (edetate disodium) are usually added, and the addition of the above auxiliary materials Played the effect of improving th

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] An atomized salbutamol solution for treating respiratory diseases, made of the following raw materials in parts by weight: 45.0 parts of salbutamol, 48.0 parts of pH regulator, 15.6 parts of budesonide, 18.5 parts of terbutaline, 20.6 parts of vitamins and pure 96.5 parts of water.

[0022] The present invention is an atomized salbutamol solution for treating respiratory diseases. The preparation process of said salbutamol is as follows: first put salicylaldehyde, tert-butylamine and ethanol into a reaction kettle, heat, stir and reflux to recover the solvent under reduced pressure, and then recycle the solvent in the solvent Add benzene and thionyl chloride to the mixture, and continue to stir, then filter and wash with benzene to obtain N,N-dimethyl chlorosulfate methylene ammonium solid, then add chloroacetic acid and dichloroethane to the solid, Stir at room temperature, then add water layer, wash with saturated sodium chloride solution and water, anhydrous Na 2 SO...

Embodiment 2

[0034] An atomized salbutamol solution for treating respiratory diseases, made of the following raw materials in parts by weight: 54.5 parts of salbutamol, 35.2 parts of a pH regulator, 24.0 parts of budesonide, 14.3 parts of terbutaline, 32.0 parts of vitamins and pure 85.6 parts of water.

[0035] The present invention is an atomized salbutamol solution for treating respiratory diseases. The preparation process of said salbutamol is as follows: first put salicylaldehyde, tert-butylamine and ethanol into a reaction kettle, heat, stir and reflux to recover the solvent under reduced pressure, and then recycle the solvent in the solvent Add benzene and thionyl chloride to the mixture, and continue to stir, then filter and wash with benzene to obtain N,N-dimethyl chlorosulfate methylene ammonium solid, then add chloroacetic acid and dichloroethane to the solid, Stir at room temperature, then add water layer, wash with saturated sodium chloride solution and water, anhydrous Na 2 ...

Embodiment 3

[0047] An atomized salbutamol solution for treating respiratory diseases, made of the following raw materials in parts by weight: 48.5 parts of salbutamol, 38.0 parts of pH regulator, 19.0 parts of budesonide, 16.5 parts of terbutaline, 22.0 parts of vitamins and pure 86.5 parts of water.

[0048] The present invention is an atomized salbutamol solution for treating respiratory diseases. The preparation process of the salbutamol is as follows: firstly, salicylaldehyde, tert-butylamine and ethanol are put into a reaction kettle, and the solvent is recovered under reduced pressure after heating, stirring and reflux; Add benzene and thionyl chloride to the mixture, and continue to stir, then filter and wash with benzene to obtain N,N-dimethyl chlorosulfate methylene ammonium solid, then add chloroacetic acid and dichloroethane to the solid, Stir at room temperature, then add water layer, wash with saturated sodium chloride solution and water, anhydrous Na 2 SO 4 Dry and filter,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an atomized salbutamol solution for treating respiratory diseases and a preparation method thereof and relates to the field of atomized salbutamol solution preparation. The atomized salbutamol solution is prepared from, by weight, 45.0-54.5 parts of salbutamol, 35.2-48.0 parts of pH regulator, 15.6-24.0 parts of budesonide, 14.3-18.5 parts of terbutaline, 20.6-32.0 parts ofvitamin and 85.6-96.5 parts of purified water. Compared with the prior art, the atomized salbutamol solution has the advantages that by adopting budesonide, terbutaline and vitamin, repair and protection of intrapulmonary mucosa are realized without impact on respiratory disease treatment; the salbutamol atomized inhalation solution has excellent stability, is little in related substance contentand simple in composition, risk of clinical medication is lowered, medication safety is improved, and the atomized salbutamol solution is simple in preparation process and has wide market prospect.

Description

technical field [0001] The invention relates to the technical field of atomized salbutamol solution, in particular to an atomized salbutamol solution for treating respiratory diseases and a preparation method thereof. Background technique [0002] Salbutamol sulfate nebulized inhalation solution Salbutamol sulfate nebulized inhalation solution, chemical name: hemisulfate of 1-(4-hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol, molecular formula: C13H21NO3. 1 / 2H2SO4, this product is a selective β2-adrenergic receptor agonist, its mechanism of action is to stimulate intracellular adenylate cyclase through the action on β-adrenergic receptors, and increase the concentration of cyclic adenosine monophosphate level, relax bronchial smooth muscle, and inhibit mediator release from immediate hypersensitivity cells (especially mast cells). Most well-controlled clinical trials have shown that albuterol has stronger respiratory effects (relaxation of bronchial smooth muscle...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/12A61K31/07A61K31/137A61K31/198A61K31/205A61K31/355A61K31/525A61K31/58A61K31/592A61K47/12A61P11/00
CPCA61K9/0073A61K31/07A61K31/137A61K31/198A61K31/205A61K31/355A61K31/525A61K31/58A61K31/592A61K47/12A61P11/00A61K2300/00
Inventor 王莹国
Owner 南京望知星医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap